DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

Herpes simplex and herpes zoster

Essential points for quick revision.

!
Eye or neurological involvement cannot wait

Eye pain, photophobia, visual change, ophthalmoplegia, meningism, altered consciousness, focal neurology or disseminated vesicles can indicate sight- or life-threatening herpesvirus disease.

Action: Arrange same-day ophthalmic or emergency specialist assessment and start indicated systemic antiviral treatment without awaiting lesion PCR in a high-risk presentation.

Synopsis

Differentiate recurrent herpes simplex from dermatomal zoster, recognise ocular, neurological and disseminated emergencies, sample appropriately and start time-sensitive antiviral treatment with renal and transmission safeguards.

  • HSV typically causes recurrent grouped painful vesicles or erosions at a mucocutaneous site; zoster causes unilateral dermatomal pain followed by vesicles that usually do not cross the midline.
  • Swab a fresh vesicle base for PCR when diagnosis is uncertain, disease is severe or genital, or the result changes infection-control or specialist decisions.
  • Herpes zoster ophthalmicus, eye pain, photophobia or visual change requires same-day ophthalmic assessment; a normal-looking eye does not cancel symptoms.

Key red flags

Ocular symptoms, Hutchinson sign, neurological deficit, meningism, disseminated lesions, eczema herpeticum, pregnancy near delivery with genital lesions, neonatal exposure or severe immunocompromise requires urgent specialist care.

Ophthalmic zoster

Forehead, upper-eyelid or nasal-tip vesicles with eye symptoms indicates trigeminal involvement and possible intraocular disease.

Investigation priorities

01
Vesicle-base HSV and VZV PCRFirst step

Distinguish herpes viruses in atypical, severe, genital or immunocompromised presentations.

Management branches

Uncomplicated eligible zosterTreat early and control pain

A unilateral dermatomal eruption is within 72 hours and age, severity, site or host risk meets antiviral criteria.

  1. Check eye, ear, neurological and dissemination features, pregnancy, immunity, renal function and medicines.
  2. Start aciclovir 800 mg five times daily or valaciclovir 1 g three times daily for seven days with renal adjustment and hydration advice.

Key medicines

Aciclovir tabletsFor herpes zoster take 800 mg orally five times daily at approximately four-hour intervals while awake for seven days.
Valaciclovir tabletsFor herpes zoster take 1 g orally three times daily for seven days, adjusted for renal function.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom